Last reviewed · How we verify
Contrast Ultrasound
Contrast Ultrasound is a Small molecule drug developed by Rabih A. Chaer. It is currently in Phase 2 development. Also known as: Definity.
At a glance
| Generic name | Contrast Ultrasound |
|---|---|
| Also known as | Definity |
| Sponsor | Rabih A. Chaer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Photo-Acoustic and Ultrasonographic Mammoscope (PHASE2)
- Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder (NA)
- Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules (NA)
- Interest of a Post-operative Ultrasound With Systematic Use of Ultrasonic Contrast in the Follow-up of Aortic Endoprosthesis: Prospective Study at the University Hospital of Nice (NA)
- CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma
- Blood-Brain Barrier Opening Using MR-Guided Focused Ultrasound in Patients With Amyotrophic Lateral Sclerosis (NA)
- A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire (PHASE4)
- Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Contrast Ultrasound CI brief — competitive landscape report
- Contrast Ultrasound updates RSS · CI watch RSS
- Rabih A. Chaer portfolio CI
Frequently asked questions about Contrast Ultrasound
What is Contrast Ultrasound?
Contrast Ultrasound is a Small molecule drug developed by Rabih A. Chaer.
Who makes Contrast Ultrasound?
Contrast Ultrasound is developed by Rabih A. Chaer (see full Rabih A. Chaer pipeline at /company/rabih-a-chaer).
Is Contrast Ultrasound also known as anything else?
Contrast Ultrasound is also known as Definity.
What development phase is Contrast Ultrasound in?
Contrast Ultrasound is in Phase 2.
Related
- Manufacturer: Rabih A. Chaer — full pipeline
- Also known as: Definity
- Compare: Contrast Ultrasound vs similar drugs
- Pricing: Contrast Ultrasound cost, discount & access